Maxus Mining Completes Inaugural Drill Program at Alturas West, Intersecting Visible Antimony Mineralization in 9 of 11 Holes

Maxus Mining completed its inaugural 1,413.5-metre, 11-hole diamond drill program at the Alturas West antimony project, testing roughly 300 metres of the Alps-Alturas shear zone. Visible antimony-bearing mineralization was observed in 9 of 11 holes, including a locally massive stibnite vein over 0.40 metres in hole ALTW-26-006. Results are preliminary and no grades have been reported; laboratory assays are expected progressively during fall 2026, while the company integrates drilling with geophysical targets extending more than 900 metres of strike.

Analysis

This is an assay-pending exploration update, not a valuation-changing event. Visual mineral identification and narrow vein occurrence provide no basis to infer contained metal, continuity, recoverability, or an economic resource; the market should discount promotional read-through until certified grades, widths, density of mineralization, and metallurgy are released. The relevant near-term risk is financing: a subscale explorer is likely to require additional equity capital before any follow-up campaign, making a transient sentiment-driven rally vulnerable to dilution.

The 1-3 month catalyst path is binary around laboratory results and, subsequently, whether results demonstrate repeatable grade-width across enough of the target to justify step-out drilling. A high-grade but narrow intercept could still disappoint because antimony projects require mineable geometry, recoveries, concentrate quality, and permitting credibility—not simply exceptional spot assays. The early ore-sorting work is potentially more consequential than the market may recognize, but only if it establishes meaningful waste rejection and acceptable antimony recovery; otherwise it is not investable evidence.

There is no clear implication for EDG: the supplied ticker does not appear economically linked to the issuer or the project. The more liquid thematic beneficiaries of sustained Western antimony-security spending are UAMY and PPTA, but neither should re-rate materially on an unverified early-stage Canadian exploration result. Structurally, incremental North American antimony discoveries increase future optionality for non-Chinese supply chains, yet the timeline to commercial supply is measured in many years and remains highly uncertain.

Key Decisions for Investors

• No position in EDG based on this item; treat the ticker association as a data-quality mismatch rather than a trading signal.
• Do not initiate MAXM/MXMGF exposure before assays. Create an event-driven watch alert for certified results over the next 1-3 months; only assess a speculative long if multiple holes show economically relevant grade-width and continuity, alongside disclosed cash runway and follow-up drill funding.
• For antimony exposure, maintain UAMY and PPTA only as separate strategic-supply-chain watch names, not as sympathy trades. Reassess if assays validate scale or if Western procurement/offtake announcements emerge; exit any thematic momentum trade if antimony prices weaken materially or financing dilution is announced.
• Key falsifiers for any eventual MAXM thesis: isolated high-grade veins without broad continuity, poor metallurgical recovery or concentrate quality, a discounted equity raise, or a follow-up program materially smaller than required to test strike and depth extensions.